0000919574-26-002769.txt : 20260508 0000919574-26-002769.hdr.sgml : 20260508 20260508111354 ACCESSION NUMBER: 0000919574-26-002769 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260508 DATE AS OF CHANGE: 20260508 EFFECTIVENESS DATE: 20260508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sofinnova BioEquities, LP CENTRAL INDEX KEY: 0001706472 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-286773 FILM NUMBER: 26956809 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 150 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-681-8482 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 150 CITY: MENLO PARK STATE: CA ZIP: 94025 D/A 1 primary_doc.xml X0708 D/A LIVE 0001706472 Sofinnova BioEquities, LP 3000 SAND HILL ROAD BUILDING 3, SUITE 150 MENLO PARK CA CALIFORNIA 94025 650-681-8482 DELAWARE None None Limited Partnership true -- -- Sofinnova BioEquities GP LLC 3000 Sand Hill Road Building 3, Suite 150 Menlo Park CA CALIFORNIA 94025 Executive Officer General Partner -- -- Sofinnova Investments, Inc. 3000 Sand Hill Road Building 3, Suite 150 Menlo Park CA CALIFORNIA 94025 Executive Officer Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000919574-25-002791 2017-01-03 true true true false 0 Indefinite 376921569 Indefinite false 77 0 true 0 true 0 true The Investment Manager receives customary management fees. true Sofinnova BioEquities, LP /s/ Jim Brody Jim Brody Chief Compliance Officer 2026-05-08